EDGAR Filing Documents for 0001607062-17-000189

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001607062-17-000189

Filing Date

2017-05-05

Accepted

2017-05-05 17:05:13

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	rgbp033117form10q.htm	10-Q	528293
2	EXHIBIT 10.2	ex10_2.htm	EX-10.2	68156
3	EXHIBIT 10.3	ex10_3.htm	EX-10.3	66997
4	EXHIBIT 10.4	ex10_4.htm	EX-10.4	64979
5	EXHIBIT 10.5	ex10_5.htm	EX-10.5	53605
6	EXHIBIT 10.6	ex10_6.htm	EX-10.6	49198
7	EXHIBIT 10.11	ex10_11.htm	EX-10.11	39043
8	EXHIBIT 31.1	ex31_1.htm	EX-31.1	8190
9	EXHIBIT 31.2	ex31_2.htm	EX-31.2	8146
10	EXHIBIT 32.1	ex32_1.htm	EX-32.1	4945
11	EXHIBIT 32.2	ex32_2.htm	EX-32.2	4851
	Complete submission text file	0001607062-17-000189.txt		2903887

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE FILE	rgbp-20170331.xml	EX-101.INS	357627
13	XBRL SCHEMA FILE	rgbp-20170331.xsd	EX-101.SCH	32193
14	XBRL CALCULATION FILE	rgbp-20170331_cal.xml	EX-101.CAL	33930
15	XBRL DEFINITION FILE	rgbp-20170331_def.xml	EX-101.DEF	138959
16	XBRL LABEL FILE	rgbp-20170331_lab.xml	EX-101.LAB	169696
17	XBRL PRESENTATION FILE	rgbp-20170331_pre.xml	EX-101.PRE	167917

Mailing Address 4700 SPRING ST #304 LA MESA CA 91942

Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404

Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)